Barinthus Biotherapeutics (BRNS) Earnings Date, Estimates & Call Transcripts $1.04 +0.03 (+2.97%) As of 01/17/2025 03:57 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Barinthus Biotherapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 19EstimatedActual EPS (Nov. 6) -$0.21 Beat By $0.23 Consensus EPS (Nov. 6) -$0.44 Barinthus Biotherapeutics posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.21, which topped analysts' consensus estimates of -$0.44 by $0.23. Quarterly revenue was reported to be $14.97 million. With a trailing EPS of -$1.49, Barinthus Biotherapeutics' earnings are expected to decrease next year, from ($1.52) to ($1.85) per share. BRNS Upcoming EarningsBarinthus Biotherapeutics' next earnings date is estimated for Wednesday, March 19, 2025, based off prior year's reporting schedules. Get Barinthus Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Barinthus Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBRNS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BRNS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Barinthus Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.37-$0.28-$0.33Q2 20252-$0.37-$0.27-$0.32Q3 20252-$0.39-$0.27-$0.33Q4 20252-$0.39-$0.27-$0.33FY 20258($1.52)($1.09)($1.31) Barinthus Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/19/2025(Estimated)-------11/6/2024Q3 2024-$0.44-$0.21+$0.23-$0.21-$14.97M8/8/2024--$0.42-$0.43 -$0.01-$0.43--5/13/2024Q1 2024-$0.64-$0.40+$0.24-$0.40--3/20/2024Q4 2023-$0.55-$0.45+$0.10-$0.45--11/9/2023Q3 2023-$0.62-$0.37+$0.25-$0.37--8/10/2023Q2 2023-$0.59-$0.62 -$0.03-$0.62$0.65M$0.33M5/12/2023Q1 2023-$0.58-$0.48+$0.10-$0.48$1.12M$0.47M3/24/2023Q4 2022-$0.43-$0.55 -$0.12-$0.55$3.07M$6.46M Barinthus Biotherapeutics Earnings - Frequently Asked Questions When is Barinthus Biotherapeutics's earnings date? Barinthus Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 19th, 2025 based off last year's report dates. Learn more on BRNS's earnings history. Did Barinthus Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Barinthus Biotherapeutics (NASDAQ:BRNS) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.44) by $0.23. Learn more on analysts' earnings estimate vs. BRNS's actual earnings. How much revenue does Barinthus Biotherapeutics generate each year? Barinthus Biotherapeutics (NASDAQ:BRNS) has a recorded annual revenue of $14.97 million. How much profit does Barinthus Biotherapeutics generate each year? Barinthus Biotherapeutics (NASDAQ:BRNS) has a recorded net income of -$73.35 million. BRNS has generated -$1.49 earnings per share over the last four quarters. What is Barinthus Biotherapeutics's EPS forecast for next year? Barinthus Biotherapeutics's earnings are expected to decrease from ($1.52) per share to ($1.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies Puma Biotechnology Earnings Biomea Fusion Earnings Cidara Therapeutics Earnings Sutro Biopharma Earnings Fate Therapeutics Earnings TScan Therapeutics Earnings INmune Bio Earnings Renovaro Earnings Kyverna Therapeutics Earnings Seres Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:BRNS) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Barinthus Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRNS Stock Alerts